The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 24% in the first half of the forecast period. Stem cell therapies accounted for the majority of the revenue in the market with an estimated market share of 59% in 2019.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report you will find 338-page report and you will receive 116 tables, 104 figures and 3 interviews – all unavailable elsewhere.

The 338-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Translational Regenerative Medicine market forecasts from 2020-2030
  • Global Translational Regenerative Medicine submarket forecasts from 2020-2030 covering:
  • Stem Cell Therapies
  • Tissue Engineered Products
  • Gene Therapies

This study discusses the late-stage clinical trials and pipeline as well as market drivers and restraints of each submarket.

Translational Regenerative Medicine regional and national market forecasts from 2020-2030, covering:
  • North America: US, Canada
  • Europe: Germany, France, UK, Italy, Spain, Rest of Europe
  • Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
  • Latin America: Brazil, Mexico, Rest of Latin America
  • Middle East & Africa: GCC Countries, South Africa, Rest of Middle East & Africa

Each regional market is further segmented by sector.

Forecasts from 2020-2030 of the selected leading products in the Global Translational Regenerative Medicine market:
  • Osteocel Plus
  • Trinity ELITE
  • TEMCELL /Prochymal
  • Apligraf
  • Dermagraft
  • Epifix
  • ReCell
  • Neovasculgen
  • IMLYGIC (talimogene laherparepvec)

Assessment of the leading companies in the Global Translational Regenerative Medicine market:
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • AxoGen, Inc.
  • MEDIPOST Co., Ltd.
  • NuVasive
  • Organogenesis Holdings, Inc.
  • Osiris Therapeutics, Inc.
  • Pharmicell Co., Ltd.
  • Takeda
  • uniQure N.V.
  • Vericell Corporation

Information on current developments, current advancements and current key approvals in the field of translational regenerative medicine market.
SWOT and Porter’s Five Force analysis of the translational regenerative medicine market